“The best strategy to hedge your shares in Apoth would be to buy 6-month European put options to protect from a loss if the FDA rejects Apoth’s new pharmaceutical.”
Exhibit 2. Market Data for 6-month European Options on Apoth Shares
Option
X
Type of Option
Call
Exercise Price
$46.00
N(d1)
0.30
N(d2)
0.21
Using the data from Exhibit 2, the number of option X contracts that Klein would have to sell to implement the hedge strategy would be closest to:
Could someone help me with this problem or perhaps point me to what page they talk about it in the reading? If we are long on the shares and are trying to hedge against a fall in share price, shouldn’t we be buying and not selling call options?
Exhibit 2. Market Data for 6-month European Options on Apoth Shares
Option
X
Type of Option
Call
Exercise Price
$46.00
N(d1)
0.30
N(d2)
0.21
Using the data from Exhibit 2, the number of option X contracts that Klein would have to sell to implement the hedge strategy would be closest to:
Could someone help me with this problem or perhaps point me to what page they talk about it in the reading? If we are long on the shares and are trying to hedge against a fall in share price, shouldn’t we be buying and not selling call options?